Advances in Mechanical Thrombectomy for Acute Ischemic Stroke Due to Large Vessel Occlusion

被引：4

作者：

Kameda-Smith M.M. ^{[1
]}

Pai A.M. ^{[1
,2
]}

Jung Y. ^{[1
,3
]}

Duda T. ^{[1
]}

van Adel B. ^{[1
,4
,5
]}

机构：

[1] Department of Surgery, McMaster University, Hamilton, ON

[2] Department of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, ON

[3] Department of Health Sciences, McMaster University, Hamilton, ON

[4] Department of Medicine, McMaster University, Hamilton, ON

[5] Department of Surgery (Neurosurgery) and Medicine (Neurology) Hamilton, General Hospital, Hamilton, L8L 2X2, ON

来源：

Critical Reviews in Biomedical Engineering | 2021年 / 49卷 / 05期

关键词：

acute ischemic stroke; emergent large vessel occlusion; EVT; thrombectomy;

D O I：

10.1615/CritRevBiomedEng.2022042563

中图分类号：

学科分类号：

摘要：

Acute ischemic stroke (AIS) is a significant cause of global morbidity and mortality, with functional implications for quality of life and long-term disability. The limitations of intravenous thrombolytic therapy for the treatment of AIS, especially for emergent large vessel occlusion (ELVO), have paved the way for alternative therapies and the rapidly evolving landscape of endovascular therapy (EVT). Here, we summarize the major landmark trials that have advanced the field largely due to ongoing biomedical engineering device development that have translated into significantly improved clinical outcomes. Our review describes the clinical success of EVT, and current and future trends. © 2021 by Begell House, Inc. www.begellhouse.com.

引用

页码：13 / 70

页数：57

共 109 条

[1]

Tracking heart disease and stroke in Canada, (2009)

[2]

Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388, 10053, pp. 1603-1658, (2016)

[3]

Astrup J, Siesjo BK, Symon L., Thresholds in cerebral ischemia-the ischemic penumbra, Stroke, 12, 6, pp. 723-725, (1981)

[4]

Heiss WD., Experimental evidence of ischemic thresholds and functional recovery, Stroke, 23, 11, pp. 1668-1672, (1992)

[5]

Branston NM, Symon L, Crockard HA, Pasztor E., Relationship between the cortical evoked potential and local cortical blood flow following acute middle cerebral artery occlusion in the baboon, Exp Neurol, 45, 2, pp. 195-208, (1974)

[6]

Jones TH, Morawetz RB, Crowell RM, Marcoux FW, FitzGibbon SJ, DeGirolami U, Ojemann RG., Thresholds of focal cerebral ischemia in awake monkeys, J Neurosurg, 54, 6, pp. 773-782, (1981)

[7]

Desai S, Pampaniya N, Patel V., Non traumatic, non aneurysmal subarachnoid hemorrhage as an unusual presentation of cerebral venous sinus thrombosis, Int J Stroke, 13, 2, (2018)

[8]

Leslie-Mazwi TM, Hamilton S, Mlynash M, Patel AB, Schwamm LH, Lansberg MG, Marks M, Hirsch JA, Albers GW., DEFUSE 3 non-dawn patients, Stroke, 50, 3, pp. 618-625, (2019)

[9]

Saver JL., Time is brain–quantified, Stroke, 37, 1, pp. 263-266, (2006)

[10]

Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, Haley EC, Lewandowski CA, Kwiatkowski TP., Early stroke treatment associated with better outcome: The NINDS rt-PA stroke study, Neurology, 55, 11, pp. 1649-1655, (2000)

← 1 2 3 4 5 6 7 8 9 10 →